AI-generated summary
The authors report on 134 patients with recalcitrant or untreated common warts treated with a 585-nm flashlamp-pumped pulsed dye laser every 3.26 weeks. Total remission occurred in 62.69% of the 126 evaluated patients, and partial remission in 21.42%. The authors conclude the laser is safe and effective, with one relapse during a median follow-up of 5.38 months.
- Participants
- 134
- Who or what was studied
- Patients with recalcitrant or untreated verrucae vulgares on the hands, feet or other sites
- Wavelengths
- 585 nm
- Limits stated in the abstract
- Eight patients were lost to follow-up, follow-up was short (median 5.38 months, range 2 to 16), and the abstract reports no control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 8 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.